Metabolomic Discoveries Licenses Max Planck Software to Improve Metabolite Profiling Services | GenomeWeb

By Uduak Grace Thomas

Metabolomics services firm Metabolomic Discoveries has acquired an exclusive license to software developed at the Max Planck Institute that it expects will improve its ability to identify metabolomic signatures for use in pharmaceutical and ag-bio research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.